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ABSTRACT Precursor cells found in the subventricular
zone (SVZ) of the adult brain can undergo cell division and
migrate long distances before differentiating into mature
neurons. We have investigated the possibility of introducing
genes stably into this population of cells. Replication-defective
adenoviruses were injected into the SVZ of the lateral ventri-
cle of adult mice. The adenoviruses carried a cDNA for the
LacZ reporter or the human p75 neurotrophin receptor, for
which species-specific antibodies are available. Injection of
the viruses into the SVZ led to efficient labeling of neuronal
precursors. Two months after viral injection, infected cells
were detected in the olfactory bulb, a significant distance from
the site of injection. Labeled periglomerular and granular
neurons with extensive dendritic arborization were found in
the olfactory bulb. These results demonstrate that foreign
genes can be efficiently introduced into neuronal precursor
cells. Furthermore, adenovirus-directed infection can lead to
long-term stable gene expression in progenitor cells found in
the adult central nervous system.
The adult mammalian brain is capable of giving rise to new
neurons from progenitor cells located in the subventricular
zone (SVZ; ref. 1). Experiments have demonstrated that these
precursor cells are mitotically active and multipotent (2-4).
Remarkably, neuronal precursors can migrate long distances
away from their site of origin and undergo terminal differen-
tiation. For example, adult progenitor cells originating near the
lateral ventricle can migrate to the olfactory bulb, where they
undergo differentiation into granular and periglomerular neu-
rons (5, 6). The restricted migratory path and the resulting cell
specification indicate that highly specific mechanisms dictate
the fate of these cells.
As a way to understand molecular mechanisms of adult
neurogenesis and to establish an efficient method of gene
transfer in the adult brain, we have explored the possibility of
using adenovirus to transfer genes into progenitor cells in the
SVZ. As a method of in vivo gene delivery, adenovirus offers
a number of distinct advantages over other available viral
vectors. The adenovirus vectors can carry up to 7.5 kb of
foreign DNA, and can be easily grown to high titer, in excess
of 1013 plaque-forming units (pfu)/ml, and can achieve 100%
infection efficiency in culture. In addition, adenoviral DNA is
not incorporated into the chromosome, thereby eliminating
the possibility of chromosomal rearrangements that could lead
to potential tumor formation. Replication-defective adenovi-
ruses have been successfully applied to a wide variety of cell
types including both postmitotic neurons and glia in the
nervous system (7-9). The ability to infect both mitotic and
postmitotic neurons can offer an advantage over retroviruses
that are restricted in their ability to infect only dividing cells.
In this report, we have applied replication-defective adeno-
viruses to adult precursor cells in the subventricular zone and
have followed the migration and differentiation of these
progenitor cells. Using recombinant adenoviruses carrying
either the LacZ or the human p75 neurotrophin receptor, the
infected precursor cells could be found to be fully differenti-
ated in the olfactory bulb, a considerable distance from the
SVZ infection site. Expression of the recombinant genes
persisted for at least two months without noticeable cytotox-
icity. These results indicate that genes can be effectively
introduced into neuronal precursor cells in the adult central
nervous system.
MATERIALS AND METHODS
Production of pAdCMV-p75 Adenoviral Vector. An adeno-
viral p75 expression vector was generated in a two-step pro-
cess: (i) construction of an adenovirus expression plasmid
carrying the cDNA of the human p75 neurotrophin receptor,
and (ii) conversion of the plasmid into an adenovirus expres-
sion vector. The human p75 cDNA subclone in pBluescript KS
(Stratagene) was digested with SmaI and Sall and ligated into
pAd5(HS)V vector at its filled-in HindIII and SalI sites. The
p75 cDNA encoded nucleotides 1-1507 of the human gene
(10). The expression plasmid contained the adenoviral DNA
sequences encoding the left-end replication origin/packaging
elements and the overlap-recombination region, which are
required for production of the adenovirus vector. The p75
adenovirus expression vector was then generated by cotrans-
fecting the pAd5-hp75 plasmid and the 33-kbXbaI fragment of
adenovirus dlAd5NCAT into 293 human embryonic kidney
cells. The 33-kb fragment corresponds to a region from
7.8-100 map units in the viral genome, lacking the left-end
origin/packaging element and the El transcription unit. Hu-
man 293 cells provide the El gene product for complemen-
tation. The p75 adenoviral vector was recovered after cotrans-
fection and the viral DNA was verified by restriction enzyme
analysis following plaque purification.
The recombinant p75 adenovirus was generated according
to published methods (11). The virus titer was 4 x 1010 pfu/ml.
The verification of a positive virus was initially based on viral
DNA analysis from a plaque-purified virus using appropriate
restriction enzymes. The recombinant LacZ virus was a gen-
erous gift from Burkhard Bewig and Ronald Crystal (12). The
titer of the LacZ virus was 1.9 x 1011 pfu/ml.
Stereotactic Adenovirus Injection.The virus stock was dia-
lyzed against 0.1 M NaCl, 10 mM Tris (pH 7.4), and 20%
glycerol to remove CsCl carried over from the viral particle
isolation procedure (11). For injection, the virus was diluted by
20:1 with L15 medium. Typically, 1.2 x 106 pfu of virus was
Abbreviations: SVZ, subventricular zone; pfu, plaque-forming unit(s);
,3-gal, f3-galactosidase; X-Gal, 5-bromo-4-chloro-3-indolyl f3-D-
galactoside; PB, phosphate buffer.
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injected in 40 or 200 nl volume into the SVZ (1 mm anterior
to bregma, 1 mm lateral, and 2.3 mm deep from the pial surface).
For ventricle injection, 12 x 106 pfu of the virus was injected in
2 p,l volume (0.4 mm posterior to bregma, 1.6 mm lateral, and 2.2
mm deep from the pial surface). For all injections, adult female
CD-1 mice at 2-4 months of age were used.
Tissue Processing and Immunohistochemistry. At 3, 7, 14,
30, and 60 days after the virus injection, animals were deeply
anesthetized using Nembutal (Abbott) and perfused transcar-
dially with 3% paraformaldehyde in 0.1 M phosphate buffer
(PB; pH 7.4). Brains were postfixed in the perfusion solution
overnight, followed by transfer to 0.1 M PB. The brain sections
were prepared on a Vibratome at 50 ,um thickness in the
sagittal or horizontal plane. Floating sections were incubated
in blocking solution containing 10% horse serum and 0.1%
Triton X-100 in 0.1 M PB for 1-2 hr, followed by 2-day
incubation in ME20.4 monoclonal supernatant at 4°C. ME20.4
is a specific monoclonal antibody that recognizes the human,
and not murine, p75 (13). ME20.4 was used without any dilution
from the original supernatant. Brain sections were then incubated
with the secondary antibody (goat anti-mouse IgG, rhodamine
conjugate; Boehringer Mannheim) at 1/200 dilution in 0.1%
Triton X-100 and 2.5% horse serum in 0.1 M PB, and subse-
quently counterstained with Hoechst 33258 at 12.5 ,ug/ml.
For LacZ immunohistochemistry, animals were perfused in
the same manner as above, except that brains were postfixed
for 2-3 hr instead of overnight. Brain sections were prepared
in the same manner as with p75. For detection of 3-galacto-
A
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sidase ((3-gal) activity, brain sections were incubated overnight
at 37°C in a solution containing 1 mg/ml 5-bromo-4-chloro-
3-indolyl f3-D-galactoside (X-Gal), 5 mM potassium ferrocya-
nide, 5 mM potassium ferricyanide, 2 mM MgCl2, 0.01%
sodium deoxycholate, 0.01% Nonidet P-40 in 0.1 M PB.
Sections were subsequently postfixed in 3% paraformaldehyde
and counterstained with HQechst 33258 at 12.5 ,ug/ml.
Si Nuclease Analysis. The p75 S1 probe was labeled by
filling in the Bsu36I site with the Klenow fragment of Esche-
richia coli DNA polymerase I in the presence of 32P-dNTPs.
For hybridization, 100 ng of the labeled probe was precipitated
with 30 ,ug of total RNA, and incubated at 42°C for 3 hr after
being heated at 65°C for 10 min in 1 x Harts [40 mM
piperazine-N,N'-bis(thanoesulfonic acid) (Pipes), 400 mM
NaCl, 1 mM EDTA] plus 80% formamide. Si digestion was
performed for 30 min at 42°C in 10 volumes of S1 nuclease
buffer (0.28 M NaCl/0.05 M sodium acetate, pH 4.6/0.5 mM
ZnSO4/20 mg/ml salmon sperm DNA) in the presence of 400
unit/ml S1 nuclease. The digested samples were analyzed on
urea/polyacrylamide gels.
Affinity Cross-Linking. Affinity cross-linking was per-
formed according to Patil et al. (13) with 1-2 x 106 cells per
each sample. For detection of p75 receptors on the cell surface,
cells were harvested 44-48 hr after viral infection and sub-
jected to binding and crosslinking at 4°C (13). Immunopre-
cipitation of crosslinked p75 was carried out using an antibody
against p75 [9992] directed against the cytoplasmic domain of
p75. The amount of p75 receptor protein was determined by
III
FIG. 1. Infection of the SVZ precursor cells with the Lac Z adenovirus. (A) Schematic diagram of the sagittal view of the adult mouse brain
showing the site of injection (I) into the SVZ of the anterior part of the lateral ventricle (LV). Cells born here migrate in an anterior direction
along the rostral migratory stream (II; RMS, thick arrows) to the olfactory bulb (III; OB), where cells migrate radially (thin dotted arrows) to form
new interneurons. (B) Expression of 13-gal at the injection site. This corresponds to site I at Fig. 2A. Note the spread of the virus to the adjacent
striatum. The picture was taken one month after injection. Dorsal is up; rostral is right. (C) Photograph showing migrating neuroblasts in the RMS
(thick arrow), two weeks after injection. Thin arrow points to the viral spread in the striatum. (D) Photograph showing a X-Gal-positive
periglomerular neuron in the olfactory bulb one month after injection. (E) Photograph showing many X-Gal-positive granule neurons in the
olfactory bulb two months after injection. In all the photographs, the nuclei stained with Hoechst 33258 are visible as white dots. The pictures were
taken from 50-,um sagittal sections. CB, cerebellum; HP, hippocampus; CC, corpus callosum; LV, lateral ventricle; RMS, rostral migratory stream;
OB, olfactory bulb; SVZ, subventricular zone; ST, striatum; GI, glomerular layer; Pgc, periglomerular cell; Gcl, granule cell layer; Gc, granule cell;
Mcl, mitral cell layer. [Bars = 500 gm (B); 150 ,um (C-E).]
Neurobiology: Yoon et al.
Proc. Natl. Acad. Sci. USA 93 (1996)
performing Western blot analysis of the total lysates against
p75. Cells were lysed 44-48 hr postinfection, and 100 ,ug of
lysates at each pfu were used for the analysis.
RESULTS
Infection of Neuronal Precursors in the SVZ with the LacZ
Adenovirus. Neurogenesis occurs in the adult vertebrate brain
(for reviews, see refs. 1 and 14). The presence of neuronal
progenitors has been demonstrated in culture (2, 4, 15) and in
vivo, the major site for these precursors is the SVZ (2, 3). In
neonatal and adult mice, the precursor cells divide and migrate
to the olfactory bulb where they differentiate into granule and
periglomerular neurons (5, 6). To test whether adenoviral
injection could label these precursor cells, we injected the
recombinant virus carrying a reporter gene, (3-gal, into the
SVZ of the lateral wall of the lateral ventricle and followed the
fate of injected SVZ cells over a two month period (Fig. 1A).
The recombinant virus was injected bilaterally at a multiplicity
of infection -of 1.2 x 106 pfu (40 nl) into five animals at 2-4
months of age. The mice were then killed at 3 days, 1 week, 2
weeks, 1 month, and 2 months, and the expression of the 13-gal
gene was assayed for its activity using X-Gal as a substrate.
At the injection site in the SVZ, cells were heavily labeled
(Fig. 1B; site I in Fig. 1A). Cells in the neighboring corpus
callosum and caudate nucleus were also labeled due to some
injection-related spread of the virus (Fig. 1 B and C). In the
case of the corpus callosum, some cells may correspond to
oligodendrocytes migrated from the SVZ, as has been re-
ported in juvenile rats (16). These cells did not migrate away
from the injection site to the cortex or striatum. In the SVZ,
continued expression of /3-gal existed at least two months
without any noticeable reduction in the level of X-Gal staining
(data not shown). Fig. 1C shows a migrating cell found in the
rostral migratory stream (site II in Fig. 1A; thick arrow). This
cell has a spindle shape, an elongated nucleus, and a leading
process typical of migrating neuroblasts. Also, some staining
was observed in the striatum due to viral spread from the
nearby injection site (thin arrow). The spread of these cells,
however, was limited to a small radius from the injection site,
without migration farther into other regions.
In the olfactory bulb, many X-Gal-positive cells were ob-
served beginning one week after the virus injection (Fig. 1 D
and E). X-Gal-positive cells were observed in the olfactory
bulb of all animals that received the LacZ virus into the SVZ.
Fig. 1E shows a representative section of the olfactory bulb
with many X-Gal-positive cells. The position of X-Gal-positive
cells suggested that they corresponded to granular (Fig. 1E)
and periglomerular interneurons (Fig. 1D; refs. 6, 17, and 18).
The localization of X-Gal-positive cells that have migrated into
the olfactory bulb is consistent with previous studies in which
a LacZ-retrovirus was injected in neonatal rats (5) and in
transplantation experiments of LacZ-positive cells in adult
mice (6).
Typically, 200-400 X-Gal-positive cells were observed in the
olfactory bulb of each experimental animal. This number is
comparable to or greater than the numbers observed after
retroviral infection in neonatal animals (5), which harbor a
larger number of proliferating precursors in the SVZ than in
the adult. Therefore, adenoviral infection resulted in the
labeling of numerous precursor cells that migrated appropri-
ately to the olfactory bulb.
Generation of a p75 Neurotrophin Receptor Adenovirus.
The LacZ adenovirus was effective in labeling SVZ precursors
in vivo without marked cytotoxicity. However, the expression
of ,B-gal was mostly confined to the cell perikaryon. To
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FIG. 2. Expression plasmid pAd5-hp75 used in constructing Ad5-hp75 virus and characterization of the virus in COS-1 cells. (A) Expression
plasmid pAd5-hp75. The left end of the adenoviral genome contains the origin of replication (ori) and the viral packaging sequence (pkg). Each
map unit corresponds to 359 bp. Adenovirus sequences from 1.0-3.8 map units were deleted and replaced with the sequence for the CMV-1
promoter, human p75, and the mouse ,B-globin polyadenylylation site. Adenovirus sequence from 7.7-11 map units provides DNA sequence for
recombination. (B) Si nuclease analysis of the mRNA made upon viral infection of COS-1 cells. Samples from COS-1 cells are shown in duplicates
at each viral pfu/cell. Lane 9 shows the probe alone, and lane 10 is the probe subjected to Si nuclease digestion in the absence of RNA. Shown
under the lanes is a schematic of the probe (thin line) and the region of protection upon Si nuclease digestion (thick line). The size of the correct
protected fragment is 950 bp as indicated by an arrow. (C) Affinity cross-linking analysis of the protein product upon viral infection in COS-1 cells.
Each lane represents 1 x 106 cells, except for PC12 cells and 3T3-p75 controls that were 2 x 106 cells. The crosslinked NGF-receptor complex
is indicated by an arrow. The number of p75 receptors present in control samples are 120,000/cell for PC12 cells and 200,000/cell for 3T3-p75 cells.
Also shown is a Western blot analysis of p75 and ,B-gal (anti-LacZ antibodies) from cells infected with both viruses at increasing viral dose.
B)
....I..
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FIG. 3. Infection of the SVZ precursor cells with the p75 adenovirus. (A) Expression of p75 in a granule cell whose dendritic processes reached
the external plexiform layer 1 month after injection. Note that the cell body is not visible in this plane of picture. (B) Photograph of mature granule
neurons at 2 month post-injection (arrows). Note that they have extensive derrdritic arborization and synaptic boutons. (C) Expression of p75 in
a periglomerular neuron (thick arrow) at the 2 month postinjection. Note the location of its cell body at the perimeter of a glomerulus (compare
with the arrow in D). Also shown are the dendritic branches of a granule neuron with synaptic boutons (thin arrow). (D) Hoechst counter staining
of C) showing that the cell body of a labeled cell in C resided at the perimeter of a glomerulus. The pictures were taken from 50-,m sagittal sections.
GI, Glomerular layer; Gc, granule cell; Gcl, granule cell layer; Pgc, periglomerular cell; Epl, external plexiform layer. [Bars = 150 ,um (A-D).]
visualize staining of the entire cell, a recombinant adenovirus
was generated that contained the human p75 neurotrophin
receptor (10). The p75 cDNA was inserted into a multiple
cloning site of the expression plasmid pAd5CMV-(H-S)V (19)
to produce pAd5-hp75 (Fig. 2A). The titer of the p75 recom-
binant adenovirus was 4 x 1010 pfu/ml based on a plaque assay
using 293 cells. To evaluate the RNA and protein products
produced by the recombinant virus, a series of infections was
first carried out in COS-1 cells. Infection of COS-1 cells
produced a correct p75 transcript, as indicated by a 950-bp
fragment in Si nuclease experiments (Fig. 2B). The 950-bp
protected fragment corresponded to the coding region of p75
and the ,B-globin poly adenylation signal. In addition, steady
state levels of transcript increased with the viral titer, indicating
the dose dependency of p75 transcription upon viral infection.
We next determined cell surface expression of the p75
receptor by affinity crosslinking with 125I-NGF (Fig. 2C
Upper). The Mr of the crosslinked protein product from
infected cells was =90 kDa, consistent with previous measure-
ments of the NGF-p75 complex (20, 21). The amount of p75
expressed on the cell surface increased as the viral dose
increased, which is reflected in the total amount of p75
detected by Western blot analysis. A similar increase in the
total amount of p75 receptor was also observed even when the
cells were coinfected with both the p75 and lacZ viruses (Fig.
2C Lower). Even at the highest viral dose, COS cells did not
display any noticeable cytotoxicity. By extrapolating from the
protein crosslinking measurements, it was estimated that viral
infection yielded a high level of expression, exceeding 800,000
receptors per infected cell. This number was derived from a
comparison with positive control cell lines, PC12 and 3T3-p75
(Fig. 2C), which had been evaluated for p75 receptor levels by
equilibrium binding and immunoblot measurements (22).
Infection ofNeuronal Precursors with the Recombinant p75
Adenovirus. The p75 recombinant adenovirus was injected
bilaterally into the SVZ of the lateral ventricle at a multiplicity
of infection of 1.2 x 106 pfu (200 nl). Five animals were
analyzed at 3 days, 1 week, 2 weeks, 1 month, and 2 months.
The pattern of p75 expression was then assessed using a
specific monoclonal antibody, ME20.4 (23), which recognizes
Neurobiology: Yoon et al.
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the human, and not murine, p75. This antibody was used
previously to detect human p75 expression in transgenic mice
(13, 24).
At the site of injection, SVZ cells were labeled in a similar
manner as with the Lac Z adenovirus. Additionally, expression
of the human p75 receptor remained high at the injection site
over two months. Beginning one week postinjection, many
p75-positive neurons were observed in the olfactory bulb. Fig.
3 shows olfactory neurons detected two months after infection
using ME20.4 immunostaining in the olfactory bulb. In con-
trast to the lacZ virus-infected cells that displayed }3-gal
expression only around the nucleus, the entire cell body and
processes were visible in p75-virus infected cells. Granule
neurons exhibited long dendritic processes, which extended to
the external plexiform layer (Fig. 3 A and B; thick arrows).
Dendritic boutons were evident among labeled granule neu-
rons, especially in their lateral branches (thick arrow in Fig. 3B
and thin arrow in 3C). At this time, ME20.4-labeled periglo-
merular neurons were also observed with extensive arboriza-
tion that reached neighboring glomeruli (thick arrow in Fig. 3
C and D).
The expression of p75 and migration of infected olfactory
neurons were specific to the SVZ injection site. Injection of
p75 virus in the lateral ventricle resulted in intense staining for
human p75 in ependymal cells lining the lateral ventricle (Fig.
4) at 4 days, 2 weeks, and 1 month postinjection, but did not
result in labeled cells in the olfactory bulb. These results
indicate that olfactory bulb interneurons are derived from the
SVZ and not from ependymal cells.
Infection of the SVZ cells with the p75 adenovirus in adult
mice resulted in labeled granular and periglomerular neurons
in the olfactory bulb 4-6 mm away from the injection site. The
fate of SVZ precursors labeled by the p75 adenovirus is
consistent with the findings using the Lac Z adenovirus. In
addition, the morphology of small interneurons observed with
ME20.4 staining is in agreement with studies in which 1,1'-
dioleyl-3,3,3' ,3 '-tetramethylindocarbocyanine methanesulfon-
ate was used to follow a small population of SVZ derived
neurons in the olfactory bulb (6). For these injected cells that
migrated and differentiated, the recombinant adenovirus in-
fection did not interfere with the normal neurogenic potential
of neuronal precursors in the SVZ, their migration or differ-
entiation in vivo. More importantly, 13-gal or p75 expression
was detected only in small interneurons that do not project
outside the olfactory bulb, indicating that the staining did not
simply result from retrograde transport of the virus. Therefore,
the ME20.4 or X-Gal-positive cells observed in the olfactory
FIG. 4. Control injection of p75 adenovirus virus in the lateral
ventricle. (A) Expression of p75 in ependymal cells lining the lateral
ventricle 2 weeks after injection (arrow). The triangle points to a single
labeled cell. Despite the intense labeling in the ependymal layer, no
ME20.4-positive cells were found in the olfactory bulb of control
animals one month after infection. (B) Hoechst staining of the same
section as A. Dorsal is up; lateral is left. The staining was carried out
on frontal sections (50 ,um). ST, striatum; LV, lateral ventricle. [Bars =
150 ,um (A-D).]
bulb originated from virally infected SVZ precursors that
followed their natural course of maturation and differentiation
to the olfactory bulb 4-6 mm away.
DISCUSSION
Our results demonstrate that adenoviruses provide an efficient
way of introducing foreign genes into neuronal precursors in
the adult brain. Infected cells were able to maintain recom-
binant gene expression following proliferation, migration, and
differentiation. Since these cells have been shown to divide
during their migration (6), cell division appears not to have
affected the functional integrity of the viral genome. The
adenoviral infection did not affect the migratory route or the
eventual fate of SVZ precursors: SVZ cells infected with the
adenovirus generated two types of interneurons, granular and
periglomerular neurons in the olfactory bulb. Since these
neurons do not project outside the olfactory bulb, the labeling
detected after viral infection was derived from SVZ precursors
that migrated into the olfactory bulb and not by retrograde
transport or diffusion. The adenoviral infection also did not
interfere with terminal differentiation of SVZ precursors. The
infected granular and periglomerular neurons in the olfactory
bulb developed a mature neuronal morphology as evidenced
by long, branched dendritic processes with synaptic boutons.
A striking result of this study was the long-term expression
of recombinant p75 and 1-gal genes, which was maintained
even 2 months after infection. Other experiments observed a
similar long-term 3-gal expression after viral infection (9).
One potential reason for the persistent recombinant gene
expression observed here may be due to continuous arrival of
infected cells from the SVZ to the olfactory bulb, thereby
replenishing dying cells in the bulb. Two observations suggest
that infected cells in the olfactory bulb live to become fully
mature: (i) the number of infected cells in the olfactory bulb
increased over the course of our study; and (ii) the p75-positive
cells displayed short processes at earlier times and gradually
developed a more mature morphology with extensive dendritic
branches.
Expression of p75 in the precursors of olfactory interneu-
rons did not disrupt their normal migration and differentia-
tion. It should be noted that a large number of activities have
been proposed for the p75 neurotrophin receptor (25). These
include increasing neurotrophin responsiveness through the
Trk tyrosine kinase receptors (26, 27); production of the
second messenger, ceramide (28); increasing rate of apoptosis
(29), effects upon cell migration (30) and NF-KB induction
(31). There was no apparent enhancement of cell death in this
population of cells due to exogenous p75 expression. The
numbers of p75-positive neurons observed in the olfactory
bulb were similar to those observed by adenoviral LacZ
infection, suggesting ectopic expression of p75 in precursor
cells does not lead to cell death in this population of cells. It
remains to be determined whether expression of p75 in
precursor cells displays any detectable phenotype, such as
enhanced survival or migratory properties.
Adult neurogenesis in the mammalian SVZ offers an in-
valuable experimental system for studying the mechanisms of
neuronal formation, especially in conjunction with the use of
adenovirus as a- method of gene delivery. For instance, it has
been hypothesized that the SVZ in the adult is comprised of
two different populations of mitotic precursors of the same
lineage; one, being a stem cell population capable of self-
renewal and the other, constitutively proliferating precursors
that give rise to olfactory interneurons (3). The evidence for
their shared lineage is, however, lacking mainly due to the lack
of suitable means to label these relatively quiescent stem cells
effectively. Since the adenovirus can infect both the mitotic
and postmitotic cells, this method may allow for the fate of
these putative stem cells to be followed in the adult brain. In
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addition, by introducing genes into the SVZ, the factors that
control their migration and differentiation into mature olfac-
tory interneurons can be studied. Genes that encode growth
factors and their receptors, cell adhesion molecules, and
components of the cell cycle will provide mechanistic clues in
the processes of neurogenesis, migration, and differentiation.
Furthermore, adenovirus-mediated delivery of genes to the
postmitotic target zone may provide a means of introducing
therapeutically relevant genes in these cells. This will depend
upon overcoming the potential cytotoxic effects from recog-
nition of viral proteins by the immune system. This report
demonstrates that the adenovirus system is feasible for study-
ing neurogenesis by targeting neuronal precursors in the adult
central nervous system, and also provides an efficient and
effective means to introduce genes into both mitotic and
postmitotic cells in the central nervous system.
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